# Rosetta Genomics Ltd. (ROSGQ)

> Healthcare · IL · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ROSGQ/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2017 | $ 1.17M | $ -2.79M | N/A | $ 2.45M | $ 1.10M |
| 2016 | $ 9.94M | $ -22.33M | N/A | $ 3.80M | $ 4.42M |
| 2015 | $ 11.61M | $ -24.35M | N/A | $ 0 | $ 19.62M |
| 2014 | $ 1.09M | $ -10.37M | N/A | $ 0 | $ 15.07M |
| 2013 | N/A | N/A | N/A | $ 0 | $ 23.63M |
| 2012 | N/A | N/A | N/A | $ 0 | $ 30.90M |
| 2011 | $ 86.7K | $ -6.12M | N/A | $ 95.0K | $ 3.44M |
| 2010 | $ 422.4K | $ -23.30M | N/A | $ 50.0K | $ -1.43M |
| 2009 | $ 227.1K | $ -24.99M | N/A | $ 1.67M | $ 6.84M |
| 2008 | $ 1.22M | $ -14.33M | $ -18.56M | $ 970.0K | $ 16.10M |
| 2007 | $ 0 | $ -22.20M | $ -13.29M | $ 263.0K | $ 23.61M |
| 2006 | $ 0 | $ -11.52M | N/A | $ 77.0K | $ 11.10M |
| 2005 | $ 0 | $ -8.85M | N/A | $ 6.41M | $ -2.32M |
| 2004 | $ 0 | $ -4.52M | N/A | $ 323.0K | $ 1.29M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 2.23 |
| Liabilities / Eq | 4.65 |
| Current Ratio | 2.09 |

## Other views

- [Metrics](https://sponda.capital/en/ROSGQ.md)
- [Charts](https://sponda.capital/en/ROSGQ/charts.md)
- [Compare](https://sponda.capital/en/ROSGQ/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.